ProfileGDS5822 / ILMN_1228777
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 13% 9% 7% 3% 32% 30% 19% 36% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11113
GSM1276600PDAC Late Ablation Control 211.59
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 17.97
GSM1276603PDAC Late Ablation 24.53
GSM1276604PDAC Late Ablation 316.132
GSM1303940PDAC Late Ablation_anti-CTLA4 115.530
GSM1303941PDAC Late Ablation_anti-CTLA4 210.519
GSM1303942PDAC Late Ablation_anti-CTLA4 317.136